Veru Inc (VERU) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Veru Inc   (NASDAQ: VERU)


Veru Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Veru Inc's ROI in the third quarter of 2026?
Veru Inc recorded a cumulative net loss of $-14 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -48.31%.

Within the Healthcare sector 48 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3127 to 3681.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Investment Change TTM -22.19 % -42.5 % -56.97 % -39.95 % -19.85 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 31 38 22 22 21
Return On Investment (TTM) -48.31 % -54.48 % -83.28 % -76.84 % -17.79 %
VERU's Overall Ranking # 3681 # 3127 # 3113 # 0 # 2692
Seq. Investment Change TTM 9.98 % 11.59 % -22.4 % -18.3 % -18.73 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -14 -14 -19 -23 -6

VERU Company Profile >> Back to VERU Roi Comparisons >> See Annual VERU Return On Investment



Return On Investment VERU's Ranking
Within: No.
Industry # 12
Sector # 49
Overall # 3681

Return On Investment Statistics
High Average Low
15.26 %
-32.6 %
-187.09 %
(Dec 31 2015)   (Jun 30 2023)



  News about Veru Inc Return on Investment ROI

Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for E...

November 5, 2024

Veru Inc. Unveils Promising Insights on Enobosarm and Broader Market Dynamics at ObesityWeek MIAMI, FL, Nov. 05, 2024 Veru Inc. (NASDAQ: VERU), a forward-thinking biopharmaceutical firm renowned for developing cutting-edge therapies in muscle preservation, oncology, and respiratory illnesses, recently spotlighted a noteworthy meta-analysis at the ObesityWeek conference held in San Antonio, Texas. The analysis underscored the potential of Enobosarm, a selective androgen receptor modulator, in optimizing weight loss among older patients grappling with obesity. Harnessing Innovation for Weight LossEnobosarm is heralded for its innovative approach in facilitating high-quality weight loss, all the while preserving muscle mass. Presenting at ObesityWeek, Veru shared compelling evidence from a robust meta-analysis, demonstrating Enobosarm s efficacy in addressing the multifaceted challenges of weight management in older populations. By focusing on muscle preservation, Enobosarm appears to offer a dual benefit of addressing both weight and overall physical robustness among aging patients.





Financial Statements
Veru Inc's III. Quarter Investments $ 31 Millions VERU's Balance sheet
Veru Inc's III. Quarter Income $ -7 Millions Quarterly VERU's Income Statement
VERU's Income by Division See VERU's Income by Division


VERU Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Investments in Millions 22 49 32 95 162
Y / Y Investment Growth -54.58 % 50.72 % -65.98 % -41.69 % 341.05 %
Net Income in Millions -23 -1 -93 -84 7
Y / Y Net Income Growth - - - - -
Annual Return On Investment -103.06 % -1.49 % -289.18 % -88.48 % 4.55 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VERU's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VERU's Competitors
Subscribers only: Roi for Veru Inc's Suppliers
Subscribers only: Return On Investment for VERU's Customers

Other Ratios
VERU's Roa VERU's Inventory Turnover Ratio VERU's Growth Rates VERU's Dividend Statistics
VERU's Profitability Ratios VERU's Asset Turnover Ratio VERU's Dividend Growth
VERU's Roe VERU's Valuation Ratios VERU's Financial Strength Ratios VERU's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-12T20:58:01+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.